Atalanta Therapeutics rakes in $110m Series A

Atalanta Therapeutics, a provider of new treatment options for neurodegenerative diseases, has raised $110 million in Series A financing.

Atalanta Therapeutics, a provider of new treatment options for neurodegenerative diseases, has raised $110 million in Series A financing. The investor was F-Prime Capital.

Source: Press Release